首页> 外文OA文献 >Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy

【2h】

Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy

机译：免疫调节寡核苷酸作为乳腺癌的新疗法：药代动力学，体外和体内抗癌活性，以及抗体治疗的增强性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hui Wang; Elizabeth R. Rayburn; Wei Wang; Ekambar R. Kandimalla; Sudhir Agrawal; Ruiwen Zhang;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apoptosis, proliferation, and potentiation of chemotherapy. [J] . Rayburn ER, Wang W, Zhang Z, The Prostate . 2006,第15期

机译：用免疫调节性寡核苷酸对前列腺癌进行实验性治疗：对肿瘤生长，凋亡，增殖和化疗增强的影响。
2. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity [J] . Baoyue Ding, Xin Wu, Wei Fan, International Journal of Nanomedicine . 2011,第6期

机译：抗DR5单克隆抗体介导的DTIC纳米粒结合化学疗法和免疫疗法治疗恶性黑色素瘤：靶标制剂的开发和体外抗癌活性
3. Dexamethasone as a chemosensitizer for breast cancer chemotherapy: Potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics [J] . Hui Wang, Ying Wang, Elizabeth R. Rayburn, International journal of oncology . 2007,第4期

机译：地塞米松作为乳腺癌化学疗法的化学增敏剂：增强阿霉素的抗肿瘤活性，调节细胞因子的表达和药代动力学
4. Curcumin based combination therapy for anti-breast cancer: from in vitro drug screening to in vivo efficacy evaluation [C] . Sunhui Chen, Qiuling Liang, Lu Sun, International Forum on Leading Edge Technologies on Crystallization Engineering and Pharmaceutics Development;Tianjin University;Tianjin Medical University . -1

机译：抗乳腺癌的姜黄素组合疗法：从体外药物筛查到体内疗效评估
5. In vitro and in vivo models for cytochrome P450-based anticancer gene therapy. [D] . Dorfman Hecht, Jodi Elise. 2002

机译：基于细胞色素P450的抗癌基因治疗的体外和体内模型。
6. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity [O] . Baoyue Ding, Xin Wu, Wei Fan, 2011

机译：抗DR5单克隆抗体介导的DTIC负载纳米粒结合化学疗法和免疫疗法治疗恶性黑色素瘤：目标制剂的开发和体外抗癌活性
7. Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity [O] . Ding, Baoyue, Wu, Xin, Fan, Wei, 2011

机译：抗DR5单克隆抗体介导的DTIC纳米粒结合化学疗法和免疫疗法治疗恶性黑色素瘤：靶标制剂的开发和体外抗癌活性
8. Does Combination Immunotherapy with Human Monoclonal Antibodies Against HER2 and CXCR4 Augment Breast Cancer Killing in Vitro and in Vivo [R] . Marasco, W. A. 2007

机译：与HER2和CXCR4的人单克隆抗体联合免疫治疗是否会增加乳腺癌的体外和体内杀伤力

Immunomodulatory oligonucleotides as novel therapy for breast cancer: pharmacokinetics, in vitro and in vivo anticancer activity, and potentiation of antibody therapy

著录项

引文网络

相似文献

相关主题

期刊订阅